ArticleBMC cancer2016

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.

Eugene Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.